Congenital muscular dystrophy, white-matter abnormalities, and neuronal migration disorders: The expanding concept

Journal of Child Neurology

Volumn 13, Issue 10, 1998, Pages 481-487

  Mackay, Mark T ^a   Kornberg, Andrew J ^a,b   Shield, Lloyd ^a   Phelan, Ethna ^a   Kean, Michael J ^a   Coleman, Lee T ^a   Dennett, Xenia ^b  

^a ROYAL CHILDREN'S HOSPITAL   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

MEROSIN;

ARTICLE; CASE REPORT; CELL MIGRATION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; LEUKOENCEPHALOPATHY; MALE; MUSCULAR DYSTROPHY; NERVE CELL; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; WHITE MATTER;

EID: 0031787976     PISSN: 08830738     EISSN: None     Source Type: Journal    
DOI: 10.1177/088307389801301003     Document Type: Article

References (38)

1. Emery AEH: Diagnostic Criteria for Neuromuscular Disorders. Baarn, The Netherlands, European Neuromuscular Centre, 1994.
2. Dubowitz V: Muscle Disorders in Childhood. London, WB Saunders, 1995.
3. Leyten QH, Gabreels FJ, Joosten EM, et al: An autosomal dominant type of congenital muscular dystrophy. Brain Dev 1986;8: 533-537.
4. nd ENMC sponsored meeting on congenital muscular dystrophy held in Baarn, The Netherlands, 14-16 May, 1993. Neuromusc Disord 1995;4:75-81.
5. th ENMC sponsored workshop on congenital muscular dystrophy, 22-24 April, 1994, The Netherlands. Neuromusc Disord 1995;5:253-258.
6. st ENMC international workshop on congenital muscular dystrophy, 8-10 March, 1996, Naarden, The Netherlands. Neuromusc Disord 1996;6:295-306.
7. Tomé FMS, Evangelista T, Leclerc A, et al: Congenital muscular dystrophy with merosin deficiency. C R Acad Sci (Paris) 1994;317: 351-357.
8. Ibraghimov-Beskrovnaya O, Ervasti JM, Leveille CJ, et al: Primary structure of dystrophin-associated glycoproteins linking dystrophin to the extracellular matrix. Nature 1992;355:696-702.
9. Ervasti JM, Campbell KP: A role for the dystrophin-glycoprotein complex as a transmembrane linker between laminin and actin. J Cell Biol 1993;122:809-823.
10. Philpot J,Sewry C, Pennock J, Dubowitz V: Clinical phenotype in congenital muscular dystrophy: Correlation with expression of merosin in skeletal muscle. Neuromusc Disord 1995;5:301-305.
11. North KN, Beggs AH: Deficiency of a skeletal muscle isoform of α-actinin (α-actinin-3) in merosin-positive congenital muscular dystrophy. Neuromusc Disord 1996;6:229-235.
12. Sunada Y, Edgar TS, Lotz BP, et al: Merosin-negative congenital muscular dystrophy associated with extensive brain abnormalities. Neurology 1995;45:2084-2089.
13. Pini A, Tomé F, Chevally M, Gobbi G: Merosin-negative congenital muscular dystrophy, cortical dysplasia and epilepsy: An association to investigate, abstract. Neuromusc Disord 1996;6:S17.
14. Van der Knaap MS, Smit LME, Barth PG, et al: Magnetic resonance imaging in classification of congenital muscular dystrophies with brain abnormalities. Ann Neurol 1997;42:50-59.
15. Fukuyama Y, Osawa M, Suzuki H: Congenital progressive muscular dystrophy of the Fukuyama type-clinical, genetic and pathological considerations. Brain Dev 1981;3:1-29.
16. Dobyns WB, Pagon RA, Armstrong D, et al: Diagnostic criteria for Walker-Warburg syndrome. Am J Med Genet 1989;32:195-210.
17. Santavuori P, Somer H, Sainio K, et al: Muscle-eye-brain disease (MEB). Brain Dev 1989;11:147-153.
18. Engvall E, Wewer UM: The domains of laminin. J Cell Biol 1996;61: 493-501.
19. Vuolteenaho R, Nissinen M, Sainio K, et al: Human laminin M chain (merosin): Complete primary structure, chromosomal assignment, and expression of the M and A chain in human fetal tissues. J Cell Biol 1994;124:381-394.
20. Sewry CA, Philpot J, Sorokin LM, et al: Diagnosis of merosin (laminin-2) deficient congenital muscular dystrophy by skin biopsy. Lancet 1996;347:582-584.
21. Voit T, Fardeau M, Tomé FMS: Prenatal detection of merosin expression in human placenta. Neuropediatrics 1994;25:332-333.
22. Sewry CA, Philpot J, Mahony D, et al: Expression of laminin subunits in congenital muscular dystrophy. Neuromusc Disord 1995;5:307-316.
23. Helbling-Leclerc A, Zhang X, Topaloglu H, et al: Mutations in the laminin α2-chain gene (LAMA 2) cause merosin-deficient congenital muscular dystrophy. Nat Genet 1995;11:216-218.
24. Cook JD, Gascon GG, Haider A, et al: Congenital muscular dystrophy with abnormal radiographic myelin pattern. J Child Neurol 1992;7(Suppl):S51-S63.
25. Echenne B, Arthuis M, Billard C, et al: Congenital muscular dystrophy and cerebral CT scan anomalies. Results of a collaborative study of the Société de Neurologie Infantile. J Neurol Sci 1986; 75:7-22.
26. Leyten QH, Gabreëls FJM, Renier WO, et al: White matter abnormalities in congenital muscular dystrophy. J Neurol Sci 1995;129: 162-169.
27. Topaloglu H, Yalaz K, Renda Y, et al: Occidental type cerebromuscular dystrophy: A report of eleven cases. J Neurol Neurosurg Psychiatry 1991;54:226-229.
28. Trevisan CP, Carollo C, Segalla P, et al: Congenital muscular dystrophy: Brain alterations in an unselected series of Western patients. J Neurol Neurosurg Psychiatry 1991;54:330-334.
29. Mercuri E, Muntoni F, Berardinelli A, et al: Somatosensory and visual evoked potentials in congenital muscular dystrophy: Correlation with MRI changes and muscle merosin status. Neuropediatrics 1995;26:3-7.
30. Kobayashi O, Hayashi Y, Arahata K, et al: Congenital muscular dystrophy: Clinical and pathologic study of 50 patients with the classical (occidental) merosin-positive form. Neurology 1997;46: 815-818.
31. Ferrie CD, Jackson GD, Giannakodimos S, Panayiotopoulos CP: Posterior agyria-pachygyria with polymicrogyria: Evidence for an inherited neuronal migration disorder. Neurology 1995;45:150-153.
32. Trevisan CP, Martinello F, Ferruzza E, Angelini C: Divergence of central nervous system involvement in 2 Italian sisters with congenital muscular dystrophy: A clinical and neuroradiological follow-up. Eur Neurol 1995;35:230-235.
33. Anton ES, Sandrock AW Jr, Matthew WD: Merosin promotes neunte growth and Schwann cell migration in vitro and nerve regeneration in vivo: Evidence using an antibody to merosin, ARM-1. Dev Biol 1994;164:133-146.
34. Hillaire D, Leclerc A, Faure S, et al: Localization of merosin-negative congenital muscular dystrophy to chromosome 6q2 by homozygosity mapping. Hum Mol Genet 1994;3:1657-1661.
35. Toda T, Segawa M, Nomura Y, et al: Localization of a gene for Fukuyama type congenital muscular dystrophy to chromosome 9q31-33. Nat Genet 1993;5:283-286.
36. Voit T, Sewry CA, Meyer K, et al: Preserved merosin M-chain (or laminin-α2) expression in skeletal muscle distinguishes Walker-Warburg syndrome from Fukuyama muscular dystrophy and merosin-deficient congenital muscular dystrophy. Neuropediatrics 1995;26:148-155.
37. Ranta S, Pihko H, Santavuori P, et al: Muscle-eye-brain disease and Fukuyama type congenital muscular dystrophy are not allelic. Neuromusc Disord 1995;5:221-225.
38. Sewry CA, Naom I, D'Alessandro M, et al: Variable clinical phenotype in merosin-deficient congenital muscular dystrophy associated with differential immunolabelling of two fragments of the laminin α2 chain. Neuromusc Disord 1997;7:169-175.